Vikram Solar Ltd. announces a new order win

The regulatory filing does not disclose a GW-by-GW tranche schedule for the 9-GW cell facility. It specifies only that first N-type TOPCon cells are targeted for December 2026, with the full 9 GW to be commissioned in phases thereafter; the size and date of each subsequent tranche are not stated. ^[2]

Commissioning timeline

Key first-phase milestones

• First cell production: The company said the first domestically produced N-type TOPCon cells are scheduled for December 2026. ^[2]
• Project readiness: Civil, clean-room and MEP work were described as progressing on schedule in the company’s Q1 FY27 call. ^[4]
• Integrated-site foundation: The facility is being developed at the nearly 200-acre Gangaikondan campus through wholly owned subsidiary VSL Green Power; the co-located 6-GW module plant was inaugurated in August 2026. ^[2]
• Ramp-up after commissioning: Commissioning of the first line is distinct from reaching full utilization; the company indicated that production would ramp after commissioning. ^[5]
• Downstream integration: Cells are intended to supply a substantial portion of Vikram Solar’s module production, while the 9-GW ingot-and-wafer facility is a later, board-approved phase targeted for FY29. ^[2]

Bottom line: The disclosed schedule supports first production in December 2026 followed by phased ramp-up to 9 GW, but it does not support a precise sequence such as 1 GW, 3 GW and 5 GW. Those tranche sizes and their individual commissioning dates could not be confirmed from the filed project update.

The Gangaikondan transition is primarily a technology and product-mix upgrade, not yet a quantifiable ASP reset. It should shift a larger portion of Vikram Solar’s output from p-type PERC toward higher-efficiency n-type TOPCon modules, while the actual ASP premium remains unconfirmed because the company has not provided technology-wise selling prices or mix targets.

Product-mix impact

• Existing portfolio: Vikram Solar’s module portfolio includes p-type monocrystalline PERC, n-type TOPCon and n-type HJT modules, across bifacial and monofacial configurations. However, the capacity split between these technologies is not separately reported. ^[6]
• Gangaikondan module platform: The site has a 6 GW module plant, inaugurated in August 2026. ^[2]
• New cell capability: The co-located facility is designed for 9 GW of n-type TOPCon cells, with first production scheduled for December 2026 and commissioning in phases. At full capacity, the cells are intended to supply the majority of Vikram Solar’s module production. ^[2]
• Strategic effect: The company moves from primarily assembling modules using imported cells toward producing high-efficiency TOPCon cells domestically and integrating them into its module output. ^[2]

This does not mean that all existing PERC capacity is immediately replaced. The new TOPCon cell capacity will be ramped in phases, while the company continues to operate a broader module portfolio that includes PERC, TOPCon and HJT. The 9 GW cell capacity also cannot be directly treated as a 9 GW replacement for PERC modules: cell and module capacities are different manufacturing stages.

ASP profile

The likely commercial change is a higher weighting toward premium, high-efficiency modules, particularly for utility-scale, rooftop and domestic-content-eligible projects. Gangaikondan is intended to support modules manufactured domestically from cell to frame for programmes where domestic-content requirements apply, as well as global customers seeking supply-chain diversification. ^[2]

However:

• No technology-wise ASP for PERC versus TOPCon is reported.
• No explicit TOPCon price premium, customer-level pricing, or target ASP mix is disclosed.
• TOPCon’s higher efficiency does not automatically guarantee a higher realised ASP; module pricing will still depend on market conditions, configuration, customer segment and competitive intensity.

Accordingly, the defensible conclusion is:

Product mix: structurally more TOPCon-oriented over time, with PERC becoming a smaller relative component if the new facility ramps as planned. ASP: potentially more premium-weighted, but the magnitude and persistence of any ASP uplift cannot be quantified from the reported information. Margin economics: the more immediate benefit is likely to come from domestic cell availability, lower logistics and supply-chain dependence, and eligibility for domestic-content demand—not from a confirmed technology-specific ASP premium. Co-location is expected to shorten supply cycles, improve quality control and lower logistics costs. ^[2]